Quantifying the Effect of Performance-Enhancing Drug Use on Fastball Velocity in Major League Baseball
Since 2005, Major League Baseball (MLB) has suspended 258 players under its Drug Prevention and Treatment Program. Moreover, the Mitchell Report yielded the names of 89 alleged users of performance-enhancing drugs (PEDs). This documentation enables quantification of the impact of PEDs on player performance. Literature with this goal is limited, and has focused primarily on batters. Some authors have examined Roger Clemens, but there has been no previous work assessing the influence of PEDs on pitchers more generally. We gathered average fastball velocity from Fangraphs.com for all MLB pitchers who threw at least 10 innings in a month between 2002 and 2008 (11,860 player months). Pitchers were deemed to be PED users if they were named as such in the Mitchell Report or suspended by MLB for a positive PED test. Human growth hormone (HGH) usage was tracked separately. We modeled fastball velocity by PED and HGH usage, age, a Starter/Reliever indicator, and several control variables. Using PEDs significantly increased average fastball velocity by 1.074 MPH overall. When PED impact was allowed to vary by pitcher type (Starter/Reliever) and age, its benefits were most substantial later in a player's career. For example, at age 35, the effect of PEDs was 1.437 MPH for relievers and 0.988 MPH for starters. HGH use was significantly negatively correlated with fastball velocity. This suggests disproportional HGH use by injured players hoping to hasten their recoveries, and is consistent with frequent explanations provided in the Mitchell Report.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 6 (2010)
Issue (Month): 2 (April)
|Contact details of provider:|| Web page: http://www.degruyter.com |
|Order Information:||Web: http://www.degruyter.com/view/j/jqas|
When requesting a correction, please mention this item's handle: RePEc:bpj:jqsprt:v:6:y:2010:i:2:n:6. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Peter Golla)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.